Skip to main content

Jacobson Lab

A KCNK16 mutation causing TALK-1 gain of function is associated with maturity-onset diabetes of the young

AUTHORS

Graff SMSarah M , Johnson SRStephanie R , Leo PJPaul J , Dadi PKPrasanna K , Dickerson MTMatthew T , Nakhe AYArya Y , McInerney-Leo AMAideen M , Marshall MMhairi , Zaborska KEKarolina E , Schaub CMCharles M , Brown MAMatthew A , Jacobson DADavid A , Duncan ELEmma L . JCI insight. 2021 07 08; 6(13).

ABSTRACT

Maturity-onset diabetes of the young (MODY) is a heterogeneous group of monogenic disorders of impaired pancreatic β cell function. The mechanisms underlying MODY include β cell KATP channel dysfunction (e.g., KCNJ11 [MODY13] or ABCC8 [MODY12] mutations); however, no other β cell channelopathies have been associated with MODY to date. Here, we have identified a nonsynonymous coding variant in KCNK16 (NM_001135105: c.341T>C, p.Leu114Pro) segregating with MODY. KCNK16 is the most abundant and β cell-restricted K+ channel transcript, encoding the two-pore-domain K+ channel TALK-1. Whole-cell K+ currents demonstrated a large gain of function with TALK-1 Leu114Pro compared with TALK-1 WT, due to greater single-channel activity. Glucose-stimulated membrane potential depolarization and Ca2+ influx were inhibited in mouse islets expressing TALK-1 Leu114Pro with less endoplasmic reticulum Ca2+ storage. TALK-1 Leu114Pro significantly blunted glucose-stimulated insulin secretion compared with TALK-1 WT in mouse and human islets. These data suggest that KCNK16 is a previously unreported gene for MODY.